| J3380 | Injection, vedolizumab, intravenous, 1 mg | 26,100 | $20 | $443.7K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,550 | $30 | $154.7K |
| J0897 | Injection, denosumab, 1 mg | 8,220 | $20 | $148K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 15,960 | $10 | $127.7K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,720 | $30 | $122.6K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 1,090 | $90 | $98.2K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 250 | $130 | $32.4K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 270 | $60 | $16.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 270 | $50 | $12K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 100 | $90 | $9K |